MIP as Drug Delivery Systems of Anticancer Agents

Abstract

This chapter reviews the use of molecularly imprinted polymers (MIP) as drug delivery systems (DDS) for anticancer agents. MIP-based DDS can not only realize the active targeting of anticancer drugs, but also respond to stimuli responsive (such as pH, temperature, infrared, etc.) specifically, thereby releasing anticancer agents specifically and realizing effective treatment of cancer. Cytotoxicity and in vivo tests on MIP-based DDS are also shown for evaluating biocompatibility and degrade.